These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4343248)

  • 21. Carcinoma of the prostate: a study of 213 patients with stage C tumors treated by total perineal prostatectomy.
    Schroeder FH; Belt E
    J Urol; 1975 Aug; 114(2):257-60. PubMed ID: 1159922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lymph node involvement in prostatic carcinoma.
    Varkarakis MJ; Murphy GP; Nelson CM; Chehval M; Moore RH; Flocks RH
    Urol Clin North Am; 1975 Feb; 2(1):197-212. PubMed ID: 1128748
    [No Abstract]   [Full Text] [Related]  

  • 23. [Prostatic carcinoma].
    Weingärtner K; Gerharz EW; Riedmiller H
    Dtsch Med Wochenschr; 1994 Feb; 119(7):235-43. PubMed ID: 7508847
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of stage 1 carcinoma of the prostate: a preliminary report.
    Blackard CE; Mellinger GT; Gleason DF
    J Urol; 1971 Nov; 106(5):729-33. PubMed ID: 5115730
    [No Abstract]   [Full Text] [Related]  

  • 25. Carcinoma of the prostate.
    Flocks RH
    J Urol; 1969 May; 101(5):741-9. PubMed ID: 5780606
    [No Abstract]   [Full Text] [Related]  

  • 26. Prognostic value of urokinase plasminogen activator for prostatic carcinoma.
    Lehmann K; Plas E; Gautschi K; Hauri D
    Urol Int; 1994; 52(3):159-61. PubMed ID: 7515534
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of Advanced Prostate Carcinoma - an Interdisciplinary Recommendation].
    Omlin A; Spahn M; Beyer J; Eberli D; Gillessen S; Jochum W; Kueng M; Nitzsche E; Rentsch CA; Roggero E; Schmid HP; Stenner F; Templeton AJ; Wild D; Wyler S; Zwahlen D; Cathomas R
    Praxis (Bern 1994); 2018 Sep; 107(19):1043-1051. PubMed ID: 30227804
    [No Abstract]   [Full Text] [Related]  

  • 28. Case study: management of advanced prostate cancer with soft tissue metastases.
    Kirby R
    Prostate Cancer Prostatic Dis; 2005; 8(3):290-2. PubMed ID: 15940287
    [No Abstract]   [Full Text] [Related]  

  • 29. Combined hormone control therapy and radical prostatectomy in the treatment of selected cases of advanced carcinoma of the prostate: a retrospective study based upon 25 years of experience.
    Scott WW; Boyd HL
    J Urol; 1969 Jan; 101(1):86-92. PubMed ID: 5812457
    [No Abstract]   [Full Text] [Related]  

  • 30. [The value of enzyme determinations in the differential diagnosis of prostatic hypertrophy and carcinoma. Parallel evaluation of the behavior of acid phosphatases, aldolase, malic and lactic dehydrogenases].
    FILIPAZZI A; LABORANTI F
    Riv Patol Clin; 1961 Dec; 16():787-96. PubMed ID: 13892860
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinicopathologic features of unsuspected regional lymph node metastases in prostatic adenocarcinoma.
    Saltzstein SL; McLaughlin AP
    Cancer; 1977 Sep; 40(3):1212-21. PubMed ID: 902239
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Remarks on prostate carcinoma and on the determination of serum phosphatases].
    BURKERT H
    Dtsch Apoth; 1961 Sep; 13():308-11. PubMed ID: 13874888
    [No Abstract]   [Full Text] [Related]  

  • 33. The natural course of prostatic carcinoma in relation to initial cytological grade.
    Adolfsson J; Fåhraeus B
    J Urol; 1988 Dec; 140(6):1452-4. PubMed ID: 3193514
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].
    Hammerer P
    Aktuelle Urol; 2004 Sep; 35(5):371-2. PubMed ID: 15384001
    [No Abstract]   [Full Text] [Related]  

  • 35. Management of transitional cell carcinoma of the prostate.
    Shenasky JH; Gillenwater JY
    J Urol; 1972 Sep; 108(3):462-5. PubMed ID: 5052255
    [No Abstract]   [Full Text] [Related]  

  • 36. Pelvic lymphadenectomy as staging before definitive treatment of prostatic carcinoma.
    Elfving P; Lundgren R
    Scand J Urol Nephrol Suppl; 1988; 110():155-61. PubMed ID: 3142034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [On the usefulness of exploring enzymatic activities in prostatic carcinomas].
    Palazzotto G; Lattuca C
    Minerva Urol; 1969; 21(1):16-20. PubMed ID: 4321991
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pro and contra -- adjuvant therapy in locoregional advanced prostatic carcinoma after radical prostatectomy].
    Ohlmann C; Heidenreich A
    Aktuelle Urol; 2004 Sep; 35(5):372-4. PubMed ID: 15478268
    [No Abstract]   [Full Text] [Related]  

  • 39. [Acid and alkaline blood phosphatase and diagnosis of prostate carcinoma].
    VAN DEN HOOFF A; SMITS G
    Ned Tijdschr Geneeskd; 1955 Apr; 99(14):1026-9. PubMed ID: 14383826
    [No Abstract]   [Full Text] [Related]  

  • 40. Massive hepatomegaly and an elevated serum acid phosphatase associated with a retrovesical carcinoma.
    KILBURN KH
    Cancer; 1958; 11(2):363-8. PubMed ID: 13511358
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.